Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10847
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNabiyeva D.A., Muhammadiyeva S.M., Nurmuxamedova N.S., Kengesbaeva M.S., Muxtorova S.K., Shomuxitdinov Sh.Sh.-
dc.date.accessioned2024-04-03T05:15:39Z-
dc.date.available2024-04-03T05:15:39Z-
dc.date.issued2024-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/10847-
dc.description.abstractMaqsad: monoterapiya (NSAID) va kombinatsiyalangan davolash (DMARDs (sulfasalazin) + NSAIDlar) paytida aksiyel spondiloartritli bemorlarda uveitning rivojlanishi va / yoki takrorlanishi xususiyatlarini baholash. Material va usullar: tarixda kamida 1 marta uveit epizodi boʻlgan, Toshkent tibbiyot akademiyasi koʻp tarmoqli klinikasi qoshidagi Respublika revmatologiya markazida ambulator davolanayotgan, ASAS mezonlari boʻyicha aksiyel spondiloartrit ishonchli tashxisi bilan 81 nafar bemor kuzatildi (2009). va o’zgartirilgan NyuYork mezonlari (1984). 68 (85%) erkaklar va 12 (15%) ayollar. Natijalar: 36 bemorga kuniga 2 g sulfasalazin va NSAIDlarnien_US
dc.language.isootheren_US
dc.publisherЎзбекистон, Тошкентen_US
dc.relation.ispartofseriesУДК;616.72-002.77:612.018.6-
dc.subjectsulfasalazin, aksial spondiloartrit, uveiten_US
dc.titleAKSIAL SPONDILOARTRIT KASALLIGIDA UVEIT RIVOJLANISHIGA BAZIS YALLIG ‘LANISHGA QARSHI DAVO VOSITALARINING TA’SIRINI BAHOLASHen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
статья_Мухаммадиева_СМ2_вестник_3_2024.pdfAKSIAL SPONDILOARTRIT KASALLIGIDA UVEIT RIVOJLANISHIGA BAZIS YALLIG ‘LANISHGA QARSHI DAVO VOSITALARINING TA’SIRINI BAHOLASH729.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.